PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 215 filers reported holding PDL BIOPHARMA INC in Q3 2015. The put-call ratio across all filers is 0.44 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $503,000 | -32.0% | 100,000 | -13.1% | 0.08% | -26.5% |
| Q2 2015 | $740,000 | -15.9% | 115,082 | -8.0% | 0.11% | -11.7% |
| Q1 2015 | $880,000 | -38.3% | 125,082 | -32.4% | 0.13% | -43.9% |
| Q4 2014 | $1,427,000 | +41.4% | 185,082 | +37.0% | 0.23% | +48.1% |
| Q3 2014 | $1,009,000 | +196.8% | 135,082 | +285.0% | 0.15% | +170.2% |
| Q2 2014 | $340,000 | -88.6% | 35,082 | -90.2% | 0.06% | -89.6% |
| Q1 2014 | $2,989,000 | – | 359,672 | – | 0.55% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Argent Trust Co | 41,405 | $102,270 | 0.01% |
| Diversified Trust Co | 11,029 | $26,469 | 0.00% |
| HANCOCK WHITNEY CORP | 128,396 | $0 | 0.00% |
| RHUMBLINE ADVISERS | 612 | $1,511 | 0.00% |
| Ancora Advisors LLC | 4,948 | $0 | 0.00% |
| Westside Investment Management, Inc. | 500 | $0 | 0.00% |